In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against organisms other than staphylococci.
Antimicrob Agents Chemother
; 46(4): 1108-11, 2002 Apr.
Article
em En
| MEDLINE
| ID: mdl-11897599
ABSTRACT
BMS-247243, a novel cephalosporin inhibitory for methicillin-resistant staphylococci, primarily has activity against gram-positive bacteria. The activities of BMS-247243, cefotaxime, and ceftriaxone against streptococci and Streptococcus pneumoniae were similar. BMS-247243 inhibits Enterococcus faecalis but not Enterococcus faecium. BMS-247243 also inhibits many inherently vancomycin-resistant species (Leuconstoc, Lactobacillus, Pediococcus) and anaerobic gram-positive bacteria.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Piridinas
/
Cefalosporinas
/
Morfolinas
/
Bactérias Gram-Positivas
Limite:
Animals
/
Female
/
Humans
Idioma:
En
Revista:
Antimicrob Agents Chemother
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Estados Unidos